Discover three Dividend Aristocrats poised for dividend growth and long-term returns.
The past month has been quite encouraging for Medtronic MDT investors. Solid first-quarter fiscal 2025 organic growth performance and several strategic initiatives to revamp the bottom line, including...
/Becton%20Dickinson%20%26%20Co_%20office%20building-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Becton, Dickinson, and Company have recently underperformed in the Nasdaq, but Wall Street analysts are optimistic about the stock’s prospects.
Shares of Hologic HOLX are showing impressive gains of late, trading quite near its 52-week high of $84.67. The stock closed Thursday at $80.99, just 4.3% below the highest point. In the past three months,...
Becton, Dickinson, and Company BDX, popularly known as BD, completed its acquisition of Edwards Lifesciences Corporation EW Critical Care product group, renaming it BD Advanced Patient Monitoring.BD had...
/Stryker%20Corp_%20HQ%20sign%20-by%20Sundry%20Photography%20via%20Shutterstock.jpg)
Despite Stryker’s outperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.
/Becton%20Dickinson%20%26%20Co_%20BACTEC%20by-%20TheBlueHydrangea%20via%20Shutterstock.jpg)
While Becton, Dickinson, and Company has failed to surpass the broader market over the past year, Wall Street analysts are highly bullish on the stock’s prospects.
Becton Dickinson: Fiscal Q3 Earnings Snapshot
Becton, Dickinson and Company is all set to release its fiscal third-quarter earnings next month, and analysts expect a double-digit profit increase.
Amid a broader market rotation out of Big Tech stocks, investors can consider these three top-rated healthcare stocks with double-digit upside potential.